BioAge Labs

BioAge files for IPO, plans pair of midstage obesity trials
Fierce Biotech
Wed, 09/4/24 - 11:40 am
BioAge Labs
IPOs
Eli Lilly
obesity
clinical trials
Eli Lilly partner BioAge raises $170 mln for obesity treatment
Reuters
Tue, 02/13/24 - 11:24 am
BioAge Labs
Eli Lilly
obesity
funding
Lilly to help BioAge test muscle regeneration therapy in combo with weight loss drug tirzepatide
Fierce Biotech
Thu, 10/26/23 - 10:46 pm
Eli Lilly
BioAge Labs
muscle regeneration
tirzepatide
Mounjaro
BGE-105
Biogen, BioAge and PTC Present Novel MoAs in Neurodegenerative Diseases
BioSpace
Mon, 11/7/22 - 10:52 am
neurodegenerative disease
Biogen
BioAge Labs
PTC Therapeutics
Anti-aging biotech upstart plucks a drug from Amgen's discard pile, pivoting from heart failure to muscle conditions
Endpoints
Wed, 04/14/21 - 09:24 am
BioAge Labs
Amgen
AMG 986
BGE-105